These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38933274)

  • 21. [Dynamic analysis of tuberculosis specific mononuclear cells in peripheral blood of HIV patients with tuberculosis].
    Zou S; Zhu Q; Guo YN; Xiang PZ; Mo GL; Chen JH; Liu K; Liang K
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Nov; 45(11):1109-1116. PubMed ID: 36344228
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children.
    Pavan Kumar N; Anuradha R; Andrade BB; Suresh N; Ganesh R; Shankar J; Kumaraswami V; Nutman TB; Babu S
    Clin Vaccine Immunol; 2013 May; 20(5):704-11. PubMed ID: 23486418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis.
    Wei M; Wu ZY; Lin JH; Li Y; Qian ZX; Xie YQ; Su H; Zhou W
    Genet Mol Res; 2015 Dec; 14(4):17182-92. PubMed ID: 26681212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
    Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
    PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
    Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
    Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
    Sutherland JS; de Jong BC; Jeffries DJ; Adetifa IM; Ota MO
    PLoS One; 2010 Aug; 5(8):e12365. PubMed ID: 20811496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis.
    Essone PN; Leboueny M; Maloupazoa Siawaya AC; Alame-Emane AK; Aboumegone Biyogo OC; Dapnet Tadatsin PH; Mveang Nzoghe A; Essamazokou DU; Mvoundza Ndjindji O; Padzys GS; Agnandji ST; Takiff H; Gicquel B; Djoba Siawaya JF
    Sci Rep; 2019 Jun; 9(1):8201. PubMed ID: 31160610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of Elevated Serum Levels of IL-10, IL-8 and TNF-β as Potential Peripheral Blood Biomarkers in Tubercular Lymphadenitis: A Prospective Observational Cohort Study.
    Abhimanyu ; Bose M; Varma-Basil M; Jain A; Sethi T; Tiwari PK; Agrawal A; Banavaliker JN; Bhowmick KT
    PLoS One; 2016; 11(1):e0145576. PubMed ID: 26784906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic changes in biomarker profiles associated with clinical and subclinical tuberculosis in a high transmission setting: a four-year follow-up study.
    Talat N; Shahid F; Dawood G; Hussain R
    Scand J Immunol; 2009 Jun; 69(6):537-46. PubMed ID: 19439015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area.
    Chegou NN; Essone PN; Loxton AG; Stanley K; Black GF; van der Spuy GD; van Helden PD; Franken KL; Parida SK; Klein MR; Kaufmann SH; Ottenhoff TH; Walzl G
    PLoS One; 2012; 7(6):e38501. PubMed ID: 22693640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
    Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
    J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis.
    van Crevel R; van der Ven-Jongekrijg J; Netea MG; de Lange W; Kullberg BJ; van der Meer JW
    J Immunol Methods; 1999 Jan; 222(1-2):145-53. PubMed ID: 10022381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak.
    Hong Y; Kim Y; Lee JJ; Lee MG; Lee CY; Kim Y; Heo J; Han SS; Lee SJ; Kim WJ; Hong JY
    BMC Infect Dis; 2019 Feb; 19(1):151. PubMed ID: 30760247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
    Hasan Z; Jamil B; Ashraf M; Islam M; Dojki M; Irfan M; Hussain R
    Clin Vaccine Immunol; 2009 Jul; 16(7):991-8. PubMed ID: 19439524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.
    Hur YG; Crampin AC; Chisambo C; Kanyika J; Houben R; Ndhlovu R; Mzembe T; Lalor MK; Saul J; Branson K; Stanley C; Ngwira B; French N; Ottenhoff TH; Dockrell HM; Gorak-Stolinska P
    Clin Vaccine Immunol; 2014 Feb; 21(2):133-42. PubMed ID: 24285818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological host responses as surveillance and prognostic markers in tubercular infections.
    Waghmare PJ; Lende T; Goswami K; Gupta A; Gupta A; Gangane N; Kumar S
    Int J Mycobacteriol; 2019; 8(2):190-195. PubMed ID: 31210165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.